We are live on ! Find out more
MVM

Medicxi Ventures Management Portfolio holdings

AUM $982M
1-Year Est. Return 210.17%
This Fund
S&P 500
This Quarter Est. Return
+44.42%
1 Year Est. Return
+210.17%
3 Year Est. Return
+787.54%
5 Year Est. Return
+404.19%
10 Year Est. Return
–
AUM
$982M
AUM Growth
+$147M
Cap. Flow
-$101M
Cap. Flow %
-10.29%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

1
RAPT
RAPT Therapeutics
RAPT
+$94.6M
2
NAMS icon
NewAmsterdam Pharma
NAMS
+$6.36M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$793M 80.76%
19,963,157
– –
NAMS icon
2
NewAmsterdam Pharma
NAMS
$3.71B
$85.6M 8.72%
2,674,182
-195,383
-7% -$6.36M
PHAT icon
3
Phathom Pharmaceuticals
PHAT
$882M
$82.9M 8.45%
7,464,572
– –
AURA icon
4
Aura Biosciences
AURA
$701M
$20.3M 2.07%
3,039,892
– –
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
– –
-2,794,000
Closed -$94.6M

Similar funds

EWA
Evolution Wealth Advisors Aventura, Florida $981M AUM 21.2% 1-Year Est. Return
RA
Rodgers & Associates Lancaster, Pennsylvania $982M AUM 15.11% 1-Year Est. Return
BIP
Blueprint Investment Partners Greensboro, North Carolina $980M AUM 27.19% 1-Year Est. Return
RA
Rational Advisors Huntington, New York $980M AUM 9.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Politan Capital Management New York $985M AUM 3.12% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $977M AUM 19.09% 1-Year Est. Return
FCM
Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return